Epilepsy Market size was valued at USD 681.41 million in 2024 and is likely to exceed USD 1.69 billion by the end of 2037, registering over 7.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of epilepsy is evaluated at USD 721.2 million.
The major factor attributed to the growth of the global market is the rising prevalence of epilepsy among the global population and increasing cases of neurological diseases around the globe. According to data from the World Health Organization (WHO), around 50 million people worldwide have epilepsy.
In addition to the aforementioned factors, the other factors responsible for significant revenue generation in the next few years are the surge of non-communicable diseases along with central nervous system disorders. Apart from it, the escalation in abnormal brain activities such as seizures, episodes of involuntary movements, and sensations owing to prenatal or perinatal complications, congenital abnormalities, or genetic conditions are considered to impetus the growth of the market size during the forecast period. In addition, numerous initiatives taken by governments and organizations to spread awareness about epilepsy are also estimated to provide growth opportunities for the expansion of the global epilepsy market in the coming years. Furthermore, the increasing geriatric population coupled with the presence of a strong healthcare base and rising healthcare expenditure are also attributed to creating a positive outlook for market growth during the forecast period. Moreover, the growing awareness amongst people regarding the treatment of neurological diseases, combined the with high adoption of antiepileptic drugs (AEDs) is also estimated to drive market growth.
Growth Drivers
Growing Prevalence of Neurological Disorders – In the recent period, the growth of neurological disorders has considerably grown up as a result of several factors such as genetic disorders, lifestyle illnesses, and accidents. Thus, for the effective treatment of these neurological disorders, the demand for epilepsy is attributed to growth in the next few years. As per recent statistics, it has been stated that more than 1 billion people around the world are being affected by some kind of neurological disease. Furthermore, nearly 7 million people worldwide die every year owing to a neurological disorder.
Rising Cases of Brain Injuries – Brain injuries result in partial or generalized seizures, sometimes along with loss of consciousness and control of bowel or bladder function. Hence, with the growth of brain injuries among the global population, it is anticipated to fuel the revenue generation of the global epilepsy market during the assessment period. The data released by the Centers for Disease Control and Prevention (CDC), in the United States region, approximately 5.3 million men, women, and children are diagnosed with a permanent Traumatic Brain Injury (TBI) and its related disability at present time.
Burgeoning Geriatric Population Across the Globe – Elderly people are more prone to brain injuries owing to their weak brain and deteriorating other body organs. Hence, the rising percentage of the geriatric population is forecasted to bring profitable opportunities for the expansion of the global epilepsy market. The statistics provided by the World Health Organization (WHO) have stated that by 2030, 1 out of 6 people in the world is forecasted to fall under 60 years and above. Also, the population share of geriatrics was 1 billion in 2020 which increased to 1.4 billion in 2022 and is anticipated to grow to reach 2.1 billion by 2050.
Rapid Expansion of the Healthcare Industry – Recent data calculated the revenue generation of the global healthcare segment to be around USD 60 billion by the end of 2023. This sector is further projected to grow till 2027 with an annual growth of 10%.
The Surge in Brain Tumors in Global Population – It was calculated that in the United States region, almost 25,000 Americans out of which around 14,000 were men and 11,000 were women were diagnosed with either brain or spinal cord tumors in 2022.
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2024-2037 |
|
CAGR |
7.2% |
|
Base Year Market Size (2024) |
USD 681.41 million |
|
Forecast Year Market Size (2037) |
USD 1.69 billion |
|
Regional Scope |
|
Diagnosis & Treatment (Imaging Devices, Blood Tests, Anti-Epileptic Drugs)
The global epilepsy market is segmented and analyzed for demand and supply by diagnosis & treatment into imaging devices, blood tests, anti-epileptic drugs, and others. Out of these, the imaging devices segment is attributed to holding the largest share of the market during the forecast period. The major factor attributed to segment growth is the increasing diagnostic imaging services across the globe and high investments made in the medical devices sector. As of 2022, the total worth of diagnostic imaging devices was estimated to be approximately USD 45 billion globally. Furthermore, the increasing advantages of imaging devices to detect and diagnose epilepsy are also estimated to bring lucrative growth opportunities for segment growth.
End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers)
The global epilepsy market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, diagnostic centers, and others. Out of these, the hospitals segment is projected to hold a significant share during the analysis period with a notable revenue generation. Effective treatment of neurological disorders and other chronic diseases is often conducted in hospitals with the availability of specialized doctors and advanced medical equipment. In addition, it’s easier and more convenient for the diagnosis and treatment processes of epilepsy. Also, the increased inflow and outflow of patients in the hospitals is another factor for the expansion of the segment size in the upcoming years.
Our in-depth analysis of the global market includes the following segments:
|
By Diagnosis & Treatment |
|
|
By Condition |
|
|
By Treatment |
|
|
By End-User |
|
North American Market Forecast
The North America epilepsy market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed to the increasing prevalence of epilepsy in the region. It is estimated that over 1.2% of the total US population had active epilepsy. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the market players to opt for easy testing of epilepsy drugs over a large target population is also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry and rising healthcare expenditure are also anticipated to boost market growth during the forecast period.
APAC Market Statistics
On the other hand, the Asia Pacific epilepsy market is also projected to grow at a significant pace with a notable CAGR rate. The growth of the market in the region can be attributed to similar factors, such as rising cases of neurological diseases and a growing geriatric population with various types of brain disorders. Also, the rapid growth of the healthcare industry and rising investment in enhancing the healthcare system are other factors that are anticipated to create a positive outlook for generating significant revenue in the forecast period. Moreover, the presence of a large pool of patients and the rapid escalation of non-communicable diseases are also expected to create a positive outlook in the upcoming years.
Yuyu Pharma along with Novartis Korea joined hands for an agreement in which Yuyu acquired the exclusive distribution rights for 3 prescription medicines, including Tegretol, a medicine containing carbamazepine used to treat conditions including epilepsy.
Koninklijke Philips N.V. announced the acquisition of BioTelemetry, Inc., a leading provider of remote diagnostics and monitoring.
Stryker B.V., a leading medical technology company, has finally acquired Wright Medical Group N.V.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?